Other concurrent condition(s)-Hypertension Posts on Medivizor
Navigation Menu

Other concurrent condition(s)-Hypertension Posts on Medivizor

Can therapy-resistant high blood pressure increase the risk of other health complications for patients with type 1 diabetes?

Can therapy-resistant high blood pressure increase the risk of other health complications for patients with type 1 diabetes?

Posted by on Jun 14, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared patients with therapy-resistant high blood pressure (HBP) and type 1 diabetes (T1D) to those who treated HBP to examine if these patients had more health complications. The results showed that patients with resistant HBP had a greater chance of having worse T1D complications, heart disease, and stroke than those...

Read More

Evaluating intensive blood pressure treatment for patients with diabetes

Evaluating intensive blood pressure treatment for patients with diabetes

Posted by on Oct 20, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the optimal blood pressure (BP) control in patients with diabetes. This study concluded that intensive BP therapy was associated with a significantly lower risk for cardiovascular events. Some background Uncontrolled BP remains a leading cause of cardiovascular diseases and death in patients with diabetes. Ideal BP...

Read More

Evaluating the effects of liraglutide on blood pressure and heart rate in patients with hypertension and T2D

Evaluating the effects of liraglutide on blood pressure and heart rate in patients with hypertension and T2D

Posted by on Oct 5, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study determined the effects of liraglutide (Victoza) on blood pressure (BP) and heart rate in patients with hypertension (abnormally high blood pressure) and poorly controlled Type 2 diabetes (T2D). This study concluded that liraglutide improved systolic BP (SBP; the first number of the BP which refers to the pressure when the heart...

Read More

What is the best target for blood pressure in people with type 2 diabetes?

What is the best target for blood pressure in people with type 2 diabetes?

Posted by on Jul 14, 2018 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the ideal blood pressure target for people with type 2 diabetes (T2D). It was determined that a systolic blood pressure (SBP, pressure when the heart contracts) of 130-139 mmHg reduced complications of high blood pressure, but there was limited evidence that lowering of SBP below 130 mmHg had benefits, and that...

Read More

Do blood sugar medications increase heart attack risk in patients with diabetes receiving dialysis for kidney disease?

Posted by on Aug 8, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated if medications used to treat high blood sugar increased the risk of heart attack in patients with diabetes and end-stage kidney disease undergoing dialysis. This study concluded that patients taking non-insulin drugs were more likely to have a heart attack. Some background Diabetes is an illness that...

Read More

Is blood pressure adequately controlled in patients with type 2 diabetes?

Is blood pressure adequately controlled in patients with type 2 diabetes?

Posted by on Mar 31, 2016 in Diabetes mellitus | 0 comments

In a nutshell This study examined whether blood pressure is adequately controlled in patients with type 2 diabetes who are at high risk of cardiovascular disease. The authors concluded that blood pressure is not sufficiently controlled in the majority of patients with type 2 diabetes. Some background Cardiovascular disease (CVD) is a common...

Read More

Efficacy and Safety of Dapagliflozin (Forxiga) in Type 2 Diabetics Treated with High Doses of Insulin

Efficacy and Safety of Dapagliflozin (Forxiga) in Type 2 Diabetics Treated with High Doses of Insulin

Posted by on Feb 23, 2013 in Diabetes mellitus | 0 comments

In a nutshell This trial assessed the efficacy and safety of a new diabetes drug, Dapagliflozin (Forxiga). Results revealed that the drug helps control difficult cases of type 2 diabetes with only moderate side-effects. Some background Dapagliflozin is a drug recently approved by the European Medicines Agency for the treatment of diabetes. Its...

Read More